ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Buprenorphine Patches Market Research Report 2024
Published Date: September 2024
|
Report Code: QYRE-Auto-2R18415
Home | Market Reports | Health| Health Conditions| Pain Management
Global Buprenorphine Patches Market Research Report 2024
BUY CHAPTERS

Global Buprenorphine Patches Market Research Report 2024

Code: QYRE-Auto-2R18415
Report
September 2024
Pages:93
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Mundipharma
Grünenthal
Purdue Pharma
Teva Pharmaceuticals
Camurus AB
Endo Pharmaceuticals
Pfizer Inc
Hisamitsu Pharmaceutical Co Inc
Alvogen
Mylan (now part of Viatris)

Buprenorphine Patches Market

Buprenorphine patches are a form of transdermal medication used primarily for pain management and, in some cases, for the treatment of opioid dependence. Buprenorphine is a partial opioid agonist, which means it activates opioid receptors in the brain but to a lesser extent than full agonists like morphine or heroin. This property makes it effective for pain relief while also reducing the risk of misuse and dependence.
The global Buprenorphine Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Buprenorphine Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Buprenorphine Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Buprenorphine Patches include Mundipharma, Grünenthal GmbH, Purdue Pharma, Teva Pharmaceuticals, Sandoz (a division of Novartis), Camurus AB, Endo Pharmaceuticals, Pfizer, Mylan (now part of Viatris), Indivior, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Buprenorphine Patches, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Buprenorphine Patches.
The Buprenorphine Patches market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Buprenorphine Patches market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Buprenorphine Patches manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Buprenorphine Patches Market Report

Report Metric Details
Report Name Buprenorphine Patches Market
Segment by Type
  • <10 Micrograms
  • ≥10 Micrograms
Segment by Application
  • Hospital
  • Clinic
  • Pharmacy
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Mundipharma, Grünenthal GmbH, Purdue Pharma, Teva Pharmaceuticals, Sandoz (a division of Novartis), Camurus AB, Endo Pharmaceuticals, Pfizer, Mylan (now part of Viatris), Indivior, Hisamitsu Pharmaceutical Co., Inc., Alvogen
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Buprenorphine Patches manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Buprenorphine Patches in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Buprenorphine Patches Market report?

Ans: The main players in the Buprenorphine Patches Market are Mundipharma, Grünenthal GmbH, Purdue Pharma, Teva Pharmaceuticals, Sandoz (a division of Novartis), Camurus AB, Endo Pharmaceuticals, Pfizer, Mylan (now part of Viatris), Indivior, Hisamitsu Pharmaceutical Co., Inc., Alvogen

What are the Application segmentation covered in the Buprenorphine Patches Market report?

Ans: The Applications covered in the Buprenorphine Patches Market report are Hospital, Clinic, Pharmacy, Other

What are the Type segmentation covered in the Buprenorphine Patches Market report?

Ans: The Types covered in the Buprenorphine Patches Market report are <10 Micrograms, ≥10 Micrograms

1 Buprenorphine Patches Market Overview
1.1 Product Definition
1.2 Buprenorphine Patches by Type
1.2.1 Global Buprenorphine Patches Market Value Comparison by Type (2024-2030)
1.2.2 <10 Micrograms
1.2.3 ≥10 Micrograms
1.3 Buprenorphine Patches by Application
1.3.1 Global Buprenorphine Patches Market Value by Application (2024-2030)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Pharmacy
1.3.5 Other
1.4 Global Buprenorphine Patches Market Size Estimates and Forecasts
1.4.1 Global Buprenorphine Patches Revenue 2019-2030
1.4.2 Global Buprenorphine Patches Sales 2019-2030
1.4.3 Global Buprenorphine Patches Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Buprenorphine Patches Market Competition by Manufacturers
2.1 Global Buprenorphine Patches Sales Market Share by Manufacturers (2019-2024)
2.2 Global Buprenorphine Patches Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Buprenorphine Patches Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Buprenorphine Patches, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Buprenorphine Patches, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Buprenorphine Patches, Product Type & Application
2.7 Global Key Manufacturers of Buprenorphine Patches, Date of Enter into This Industry
2.8 Global Buprenorphine Patches Market Competitive Situation and Trends
2.8.1 Global Buprenorphine Patches Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Buprenorphine Patches Players Market Share by Revenue
2.8.3 Global Buprenorphine Patches Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Buprenorphine Patches Market Scenario by Region
3.1 Global Buprenorphine Patches Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Buprenorphine Patches Sales by Region: 2019-2030
3.2.1 Global Buprenorphine Patches Sales by Region: 2019-2024
3.2.2 Global Buprenorphine Patches Sales by Region: 2025-2030
3.3 Global Buprenorphine Patches Revenue by Region: 2019-2030
3.3.1 Global Buprenorphine Patches Revenue by Region: 2019-2024
3.3.2 Global Buprenorphine Patches Revenue by Region: 2025-2030
3.4 North America Buprenorphine Patches Market Facts & Figures by Country
3.4.1 North America Buprenorphine Patches Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Buprenorphine Patches Sales by Country (2019-2030)
3.4.3 North America Buprenorphine Patches Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Buprenorphine Patches Market Facts & Figures by Country
3.5.1 Europe Buprenorphine Patches Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Buprenorphine Patches Sales by Country (2019-2030)
3.5.3 Europe Buprenorphine Patches Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Buprenorphine Patches Market Facts & Figures by Region
3.6.1 Asia Pacific Buprenorphine Patches Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Buprenorphine Patches Sales by Region (2019-2030)
3.6.3 Asia Pacific Buprenorphine Patches Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Buprenorphine Patches Market Facts & Figures by Country
3.7.1 Latin America Buprenorphine Patches Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Buprenorphine Patches Sales by Country (2019-2030)
3.7.3 Latin America Buprenorphine Patches Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Buprenorphine Patches Market Facts & Figures by Country
3.8.1 Middle East and Africa Buprenorphine Patches Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Buprenorphine Patches Sales by Country (2019-2030)
3.8.3 Middle East and Africa Buprenorphine Patches Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Buprenorphine Patches Sales by Type (2019-2030)
4.1.1 Global Buprenorphine Patches Sales by Type (2019-2024)
4.1.2 Global Buprenorphine Patches Sales by Type (2025-2030)
4.1.3 Global Buprenorphine Patches Sales Market Share by Type (2019-2030)
4.2 Global Buprenorphine Patches Revenue by Type (2019-2030)
4.2.1 Global Buprenorphine Patches Revenue by Type (2019-2024)
4.2.2 Global Buprenorphine Patches Revenue by Type (2025-2030)
4.2.3 Global Buprenorphine Patches Revenue Market Share by Type (2019-2030)
4.3 Global Buprenorphine Patches Price by Type (2019-2030)
5 Segment by Application
5.1 Global Buprenorphine Patches Sales by Application (2019-2030)
5.1.1 Global Buprenorphine Patches Sales by Application (2019-2024)
5.1.2 Global Buprenorphine Patches Sales by Application (2025-2030)
5.1.3 Global Buprenorphine Patches Sales Market Share by Application (2019-2030)
5.2 Global Buprenorphine Patches Revenue by Application (2019-2030)
5.2.1 Global Buprenorphine Patches Revenue by Application (2019-2024)
5.2.2 Global Buprenorphine Patches Revenue by Application (2025-2030)
5.2.3 Global Buprenorphine Patches Revenue Market Share by Application (2019-2030)
5.3 Global Buprenorphine Patches Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Mundipharma
6.1.1 Mundipharma Company Information
6.1.2 Mundipharma Description and Business Overview
6.1.3 Mundipharma Buprenorphine Patches Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Mundipharma Buprenorphine Patches Product Portfolio
6.1.5 Mundipharma Recent Developments/Updates
6.2 Grünenthal GmbH
6.2.1 Grünenthal GmbH Company Information
6.2.2 Grünenthal GmbH Description and Business Overview
6.2.3 Grünenthal GmbH Buprenorphine Patches Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Grünenthal GmbH Buprenorphine Patches Product Portfolio
6.2.5 Grünenthal GmbH Recent Developments/Updates
6.3 Purdue Pharma
6.3.1 Purdue Pharma Company Information
6.3.2 Purdue Pharma Description and Business Overview
6.3.3 Purdue Pharma Buprenorphine Patches Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Purdue Pharma Buprenorphine Patches Product Portfolio
6.3.5 Purdue Pharma Recent Developments/Updates
6.4 Teva Pharmaceuticals
6.4.1 Teva Pharmaceuticals Company Information
6.4.2 Teva Pharmaceuticals Description and Business Overview
6.4.3 Teva Pharmaceuticals Buprenorphine Patches Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Teva Pharmaceuticals Buprenorphine Patches Product Portfolio
6.4.5 Teva Pharmaceuticals Recent Developments/Updates
6.5 Sandoz (a division of Novartis)
6.5.1 Sandoz (a division of Novartis) Company Information
6.5.2 Sandoz (a division of Novartis) Description and Business Overview
6.5.3 Sandoz (a division of Novartis) Buprenorphine Patches Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Sandoz (a division of Novartis) Buprenorphine Patches Product Portfolio
6.5.5 Sandoz (a division of Novartis) Recent Developments/Updates
6.6 Camurus AB
6.6.1 Camurus AB Company Information
6.6.2 Camurus AB Description and Business Overview
6.6.3 Camurus AB Buprenorphine Patches Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Camurus AB Buprenorphine Patches Product Portfolio
6.6.5 Camurus AB Recent Developments/Updates
6.7 Endo Pharmaceuticals
6.7.1 Endo Pharmaceuticals Company Information
6.7.2 Endo Pharmaceuticals Description and Business Overview
6.7.3 Endo Pharmaceuticals Buprenorphine Patches Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Endo Pharmaceuticals Buprenorphine Patches Product Portfolio
6.7.5 Endo Pharmaceuticals Recent Developments/Updates
6.8 Pfizer
6.8.1 Pfizer Company Information
6.8.2 Pfizer Description and Business Overview
6.8.3 Pfizer Buprenorphine Patches Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Pfizer Buprenorphine Patches Product Portfolio
6.8.5 Pfizer Recent Developments/Updates
6.9 Mylan (now part of Viatris)
6.9.1 Mylan (now part of Viatris) Company Information
6.9.2 Mylan (now part of Viatris) Description and Business Overview
6.9.3 Mylan (now part of Viatris) Buprenorphine Patches Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Mylan (now part of Viatris) Buprenorphine Patches Product Portfolio
6.9.5 Mylan (now part of Viatris) Recent Developments/Updates
6.10 Indivior
6.10.1 Indivior Company Information
6.10.2 Indivior Description and Business Overview
6.10.3 Indivior Buprenorphine Patches Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Indivior Buprenorphine Patches Product Portfolio
6.10.5 Indivior Recent Developments/Updates
6.11 Hisamitsu Pharmaceutical Co., Inc.
6.11.1 Hisamitsu Pharmaceutical Co., Inc. Company Information
6.11.2 Hisamitsu Pharmaceutical Co., Inc. Description and Business Overview
6.11.3 Hisamitsu Pharmaceutical Co., Inc. Buprenorphine Patches Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Hisamitsu Pharmaceutical Co., Inc. Buprenorphine Patches Product Portfolio
6.11.5 Hisamitsu Pharmaceutical Co., Inc. Recent Developments/Updates
6.12 Alvogen
6.12.1 Alvogen Company Information
6.12.2 Alvogen Description and Business Overview
6.12.3 Alvogen Buprenorphine Patches Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Alvogen Buprenorphine Patches Product Portfolio
6.12.5 Alvogen Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Buprenorphine Patches Industry Chain Analysis
7.2 Buprenorphine Patches Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Buprenorphine Patches Production Mode & Process
7.4 Buprenorphine Patches Sales and Marketing
7.4.1 Buprenorphine Patches Sales Channels
7.4.2 Buprenorphine Patches Distributors
7.5 Buprenorphine Patches Customers
8 Buprenorphine Patches Market Dynamics
8.1 Buprenorphine Patches Industry Trends
8.2 Buprenorphine Patches Market Drivers
8.3 Buprenorphine Patches Market Challenges
8.4 Buprenorphine Patches Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Mundipharma
Grünenthal
Purdue Pharma
Teva Pharmaceuticals
Camurus AB
Endo Pharmaceuticals
Pfizer Inc
Hisamitsu Pharmaceutical Co Inc
Alvogen
Mylan (now part of Viatris)
List of Tables
 Table 1. Global Buprenorphine Patches Market Value Comparison by Type (2024-2030) & (US$ Million)
 Table 2. Global Buprenorphine Patches Market Value by Application (2024-2030) & (US$ Million)
 Table 3. Global Buprenorphine Patches Market Competitive Situation by Manufacturers in 2023
 Table 4. Global Buprenorphine Patches Sales (K Units) of Key Manufacturers (2019-2024)
 Table 5. Global Buprenorphine Patches Sales Market Share by Manufacturers (2019-2024)
 Table 6. Global Buprenorphine Patches Revenue (US$ Million) by Manufacturers (2019-2024)
 Table 7. Global Buprenorphine Patches Revenue Share by Manufacturers (2019-2024)
 Table 8. Global Market Buprenorphine Patches Average Price (US$/Unit) of Key Manufacturers (2019-2024)
 Table 9. Global Key Players of Buprenorphine Patches, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Buprenorphine Patches, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Buprenorphine Patches, Product Type & Application
 Table 12. Global Key Manufacturers of Buprenorphine Patches, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Buprenorphine Patches by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Buprenorphine Patches as of 2023)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Buprenorphine Patches Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 17. Global Buprenorphine Patches Sales by Region (2019-2024) & (K Units)
 Table 18. Global Buprenorphine Patches Sales Market Share by Region (2019-2024)
 Table 19. Global Buprenorphine Patches Sales by Region (2025-2030) & (K Units)
 Table 20. Global Buprenorphine Patches Sales Market Share by Region (2025-2030)
 Table 21. Global Buprenorphine Patches Revenue by Region (2019-2024) & (US$ Million)
 Table 22. Global Buprenorphine Patches Revenue Market Share by Region (2019-2024)
 Table 23. Global Buprenorphine Patches Revenue by Region (2025-2030) & (US$ Million)
 Table 24. Global Buprenorphine Patches Revenue Market Share by Region (2025-2030)
 Table 25. North America Buprenorphine Patches Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 26. North America Buprenorphine Patches Sales by Country (2019-2024) & (K Units)
 Table 27. North America Buprenorphine Patches Sales by Country (2025-2030) & (K Units)
 Table 28. North America Buprenorphine Patches Revenue by Country (2019-2024) & (US$ Million)
 Table 29. North America Buprenorphine Patches Revenue by Country (2025-2030) & (US$ Million)
 Table 30. Europe Buprenorphine Patches Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 31. Europe Buprenorphine Patches Sales by Country (2019-2024) & (K Units)
 Table 32. Europe Buprenorphine Patches Sales by Country (2025-2030) & (K Units)
 Table 33. Europe Buprenorphine Patches Revenue by Country (2019-2024) & (US$ Million)
 Table 34. Europe Buprenorphine Patches Revenue by Country (2025-2030) & (US$ Million)
 Table 35. Asia Pacific Buprenorphine Patches Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 36. Asia Pacific Buprenorphine Patches Sales by Region (2019-2024) & (K Units)
 Table 37. Asia Pacific Buprenorphine Patches Sales by Region (2025-2030) & (K Units)
 Table 38. Asia Pacific Buprenorphine Patches Revenue by Region (2019-2024) & (US$ Million)
 Table 39. Asia Pacific Buprenorphine Patches Revenue by Region (2025-2030) & (US$ Million)
 Table 40. Latin America Buprenorphine Patches Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 41. Latin America Buprenorphine Patches Sales by Country (2019-2024) & (K Units)
 Table 42. Latin America Buprenorphine Patches Sales by Country (2025-2030) & (K Units)
 Table 43. Latin America Buprenorphine Patches Revenue by Country (2019-2024) & (US$ Million)
 Table 44. Latin America Buprenorphine Patches Revenue Market Share by Country (2019-2024)
 Table 45. Middle East and Africa Buprenorphine Patches Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 46. Middle East and Africa Buprenorphine Patches Sales by Country (2019-2024) & (K Units)
 Table 47. Middle East and Africa Buprenorphine Patches Sales by Country (2025-2030) & (K Units)
 Table 48. Middle East and Africa Buprenorphine Patches Revenue by Country (2019-2024) & (US$ Million)
 Table 49. Middle East and Africa Buprenorphine Patches Revenue by Country (2025-2030) & (US$ Million)
 Table 50. Global Buprenorphine Patches Sales (K Units) by Type (2019-2024)
 Table 51. Global Buprenorphine Patches Sales (K Units) by Type (2025-2030)
 Table 52. Global Buprenorphine Patches Sales Market Share by Type (2019-2024)
 Table 53. Global Buprenorphine Patches Sales Market Share by Type (2025-2030)
 Table 54. Global Buprenorphine Patches Revenue (US$ Million) by Type (2019-2024)
 Table 55. Global Buprenorphine Patches Revenue (US$ Million) by Type (2025-2030)
 Table 56. Global Buprenorphine Patches Revenue Market Share by Type (2019-2024)
 Table 57. Global Buprenorphine Patches Revenue Market Share by Type (2025-2030)
 Table 58. Global Buprenorphine Patches Price (US$/Unit) by Type (2019-2024)
 Table 59. Global Buprenorphine Patches Price (US$/Unit) by Type (2025-2030)
 Table 60. Global Buprenorphine Patches Sales (K Units) by Application (2019-2024)
 Table 61. Global Buprenorphine Patches Sales (K Units) by Application (2025-2030)
 Table 62. Global Buprenorphine Patches Sales Market Share by Application (2019-2024)
 Table 63. Global Buprenorphine Patches Sales Market Share by Application (2025-2030)
 Table 64. Global Buprenorphine Patches Revenue (US$ Million) by Application (2019-2024)
 Table 65. Global Buprenorphine Patches Revenue (US$ Million) by Application (2025-2030)
 Table 66. Global Buprenorphine Patches Revenue Market Share by Application (2019-2024)
 Table 67. Global Buprenorphine Patches Revenue Market Share by Application (2025-2030)
 Table 68. Global Buprenorphine Patches Price (US$/Unit) by Application (2019-2024)
 Table 69. Global Buprenorphine Patches Price (US$/Unit) by Application (2025-2030)
 Table 70. Mundipharma Company Information
 Table 71. Mundipharma Description and Business Overview
 Table 72. Mundipharma Buprenorphine Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 73. Mundipharma Buprenorphine Patches Product
 Table 74. Mundipharma Recent Developments/Updates
 Table 75. Grünenthal GmbH Company Information
 Table 76. Grünenthal GmbH Description and Business Overview
 Table 77. Grünenthal GmbH Buprenorphine Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 78. Grünenthal GmbH Buprenorphine Patches Product
 Table 79. Grünenthal GmbH Recent Developments/Updates
 Table 80. Purdue Pharma Company Information
 Table 81. Purdue Pharma Description and Business Overview
 Table 82. Purdue Pharma Buprenorphine Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 83. Purdue Pharma Buprenorphine Patches Product
 Table 84. Purdue Pharma Recent Developments/Updates
 Table 85. Teva Pharmaceuticals Company Information
 Table 86. Teva Pharmaceuticals Description and Business Overview
 Table 87. Teva Pharmaceuticals Buprenorphine Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 88. Teva Pharmaceuticals Buprenorphine Patches Product
 Table 89. Teva Pharmaceuticals Recent Developments/Updates
 Table 90. Sandoz (a division of Novartis) Company Information
 Table 91. Sandoz (a division of Novartis) Description and Business Overview
 Table 92. Sandoz (a division of Novartis) Buprenorphine Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 93. Sandoz (a division of Novartis) Buprenorphine Patches Product
 Table 94. Sandoz (a division of Novartis) Recent Developments/Updates
 Table 95. Camurus AB Company Information
 Table 96. Camurus AB Description and Business Overview
 Table 97. Camurus AB Buprenorphine Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 98. Camurus AB Buprenorphine Patches Product
 Table 99. Camurus AB Recent Developments/Updates
 Table 100. Endo Pharmaceuticals Company Information
 Table 101. Endo Pharmaceuticals Description and Business Overview
 Table 102. Endo Pharmaceuticals Buprenorphine Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 103. Endo Pharmaceuticals Buprenorphine Patches Product
 Table 104. Endo Pharmaceuticals Recent Developments/Updates
 Table 105. Pfizer Company Information
 Table 106. Pfizer Description and Business Overview
 Table 107. Pfizer Buprenorphine Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 108. Pfizer Buprenorphine Patches Product
 Table 109. Pfizer Recent Developments/Updates
 Table 110. Mylan (now part of Viatris) Company Information
 Table 111. Mylan (now part of Viatris) Description and Business Overview
 Table 112. Mylan (now part of Viatris) Buprenorphine Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 113. Mylan (now part of Viatris) Buprenorphine Patches Product
 Table 114. Mylan (now part of Viatris) Recent Developments/Updates
 Table 115. Indivior Company Information
 Table 116. Indivior Description and Business Overview
 Table 117. Indivior Buprenorphine Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 118. Indivior Buprenorphine Patches Product
 Table 119. Indivior Recent Developments/Updates
 Table 120. Hisamitsu Pharmaceutical Co., Inc. Company Information
 Table 121. Hisamitsu Pharmaceutical Co., Inc. Description and Business Overview
 Table 122. Hisamitsu Pharmaceutical Co., Inc. Buprenorphine Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 123. Hisamitsu Pharmaceutical Co., Inc. Buprenorphine Patches Product
 Table 124. Hisamitsu Pharmaceutical Co., Inc. Recent Developments/Updates
 Table 125. Alvogen Company Information
 Table 126. Alvogen Description and Business Overview
 Table 127. Alvogen Buprenorphine Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 128. Alvogen Buprenorphine Patches Product
 Table 129. Alvogen Recent Developments/Updates
 Table 130. Key Raw Materials Lists
 Table 131. Raw Materials Key Suppliers Lists
 Table 132. Buprenorphine Patches Distributors List
 Table 133. Buprenorphine Patches Customers List
 Table 134. Buprenorphine Patches Market Trends
 Table 135. Buprenorphine Patches Market Drivers
 Table 136. Buprenorphine Patches Market Challenges
 Table 137. Buprenorphine Patches Market Restraints
 Table 138. Research Programs/Design for This Report
 Table 139. Key Data Information from Secondary Sources
 Table 140. Key Data Information from Primary Sources
 Table 141. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Buprenorphine Patches
 Figure 2. Global Buprenorphine Patches Market Value Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Buprenorphine Patches Market Share by Type: 2023 & 2030
 Figure 4. <10 Micrograms Product Picture
 Figure 5. ≥10 Micrograms Product Picture
 Figure 6. Global Buprenorphine Patches Market Value by Application (2024-2030) & (US$ Million)
 Figure 7. Global Buprenorphine Patches Market Share by Application: 2023 & 2030
 Figure 8. Hospital
 Figure 9. Clinic
 Figure 10. Pharmacy
 Figure 11. Other
 Figure 12. Global Buprenorphine Patches Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 13. Global Buprenorphine Patches Market Size (2019-2030) & (US$ Million)
 Figure 14. Global Buprenorphine Patches Sales (2019-2030) & (K Units)
 Figure 15. Global Buprenorphine Patches Average Price (US$/Unit) & (2019-2030)
 Figure 16. Buprenorphine Patches Report Years Considered
 Figure 17. Buprenorphine Patches Sales Share by Manufacturers in 2023
 Figure 18. Global Buprenorphine Patches Revenue Share by Manufacturers in 2023
 Figure 19. Global 5 and 10 Largest Buprenorphine Patches Players: Market Share by Revenue in Buprenorphine Patches in 2023
 Figure 20. Buprenorphine Patches Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
 Figure 21. Global Buprenorphine Patches Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Figure 22. North America Buprenorphine Patches Sales Market Share by Country (2019-2030)
 Figure 23. North America Buprenorphine Patches Revenue Market Share by Country (2019-2030)
 Figure 24. United States Buprenorphine Patches Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 25. Canada Buprenorphine Patches Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 26. Europe Buprenorphine Patches Sales Market Share by Country (2019-2030)
 Figure 27. Europe Buprenorphine Patches Revenue Market Share by Country (2019-2030)
 Figure 28. Germany Buprenorphine Patches Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 29. France Buprenorphine Patches Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 30. U.K. Buprenorphine Patches Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 31. Italy Buprenorphine Patches Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 32. Russia Buprenorphine Patches Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 33. Asia Pacific Buprenorphine Patches Sales Market Share by Region (2019-2030)
 Figure 34. Asia Pacific Buprenorphine Patches Revenue Market Share by Region (2019-2030)
 Figure 35. China Buprenorphine Patches Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 36. Japan Buprenorphine Patches Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 37. South Korea Buprenorphine Patches Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 38. India Buprenorphine Patches Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 39. Australia Buprenorphine Patches Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 40. China Taiwan Buprenorphine Patches Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 41. Southeast Asia Buprenorphine Patches Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 42. Latin America Buprenorphine Patches Sales Market Share by Country (2019-2030)
 Figure 43. Mexico Buprenorphine Patches Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 44. Brazil Buprenorphine Patches Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 45. Argentina Buprenorphine Patches Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 46. Colombia Buprenorphine Patches Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 47. Middle East and Africa Buprenorphine Patches Sales Market Share by Country (2019-2030)
 Figure 48. Middle East and Africa Buprenorphine Patches Revenue Market Share by Country (2019-2030)
 Figure 49. Turkey Buprenorphine Patches Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 50. Saudi Arabia Buprenorphine Patches Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 51. UAE Buprenorphine Patches Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 52. Global Sales Market Share of Buprenorphine Patches by Type (2019-2030)
 Figure 53. Global Revenue Market Share of Buprenorphine Patches by Type (2019-2030)
 Figure 54. Global Buprenorphine Patches Price (US$/Unit) by Type (2019-2030)
 Figure 55. Global Sales Market Share of Buprenorphine Patches by Application (2019-2030)
 Figure 56. Global Revenue Market Share of Buprenorphine Patches by Application (2019-2030)
 Figure 57. Global Buprenorphine Patches Price (US$/Unit) by Application (2019-2030)
 Figure 58. Buprenorphine Patches Value Chain
 Figure 59. Buprenorphine Patches Production Process
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Leap India

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions